{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:13:59Z","timestamp":1761178439619,"version":"build-2065373602"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.canrad.2013.11.009","type":"journal-article","created":{"date-parts":[[2014,1,22]],"date-time":"2014-01-22T14:18:45Z","timestamp":1390400325000},"page":"147-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Radioth\u00e9rapie des lymphomes NK\/T localis\u00e9s aux fosses nasales"],"prefix":"10.1016","volume":"18","author":[{"given":"F.-G.","family":"Riet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.-H.","family":"Canova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gabarre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ben Hassine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Kamsu Kom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-J.","family":"Mazeron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Feuvret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2013.11.009_bib0005","series-title":"World Health Organization Classification of Tumours, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"285","article-title":"Extranodal NK\/T-cell lymphoma, nasal type","author":"Chan","year":"2008"},{"key":"10.1016\/j.canrad.2013.11.009_bib0010","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008\u00a0revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2013.11.009_bib0015","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting\u00a0\u2013\u00a0Airlie House, Virginia, November 1997","volume":"17","author":"Harris","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0020","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/annonc\/mdi037","article-title":"Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single centre experience of 10years","volume":"16","author":"Au","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0025","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/annonc\/mdn147","article-title":"Clinical heterogeneity of extranodal NK\/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group","volume":"19","author":"Kim","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0030","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","article-title":"Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136\u00a0cases from the International Peripheral T-Cell Lymphoma Project","volume":"113","author":"Au","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2013.11.009_bib0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0167-8140(01)00428-5","article-title":"Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck","volume":"61","author":"Kim","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jjco\/hyi006","article-title":"Treatment outcome of angiocentric T-cell and NK\/T-cell lymphoma, nasal type: radiotherapy versus chemoradiotherapy","volume":"35","author":"Kim","year":"2005","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0045","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/hed.20314","article-title":"Outcome of patients with nasal natural killer (NK)\/T-cell lymphoma treated with radiotherapy, with or without chemotherapy","volume":"28","author":"Tham","year":"2006","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2013.11.009_bib0050","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1200\/JCO.2000.18.1.54","article-title":"Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment","volume":"18","author":"Kim","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0055","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/cncr.11908","article-title":"Treatment outcome and pattern of failure in 77\u00a0patients with sinonasal natural killer\/T-cell or T-cell lymphoma","volume":"100","author":"Li","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2013.11.009_bib0060","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1182\/blood-2005-05-2056","article-title":"Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)\/II(E) extranodal NK\/T-cell lymphoma, nasal type","volume":"106","author":"Kim","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2013.11.009_bib0065","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2005.04.1384","article-title":"Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0070","series-title":"World Health Organization Classification of Tumours, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"276","article-title":"Aggressive NK-cell leukaemia","author":"Chan","year":"2008"},{"key":"10.1016\/j.canrad.2013.11.009_bib0075","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1309\/2F39NX1AL3L54WU8","article-title":"NK-cell lymphomas and leukemias: a spectrum of tumors with variable manifestations and immunophenotype","volume":"127","author":"Hasserjian","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0080","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/sj.leu.2403955","article-title":"Natural killer-cell malignancies: diagnosis and treatment","volume":"19","author":"Kwong","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.canrad.2013.11.009_bib0085","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1182\/blood.V89.12.4501","article-title":"Non-nasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49\u00a0cases of an uncommon aggressive neoplasm","volume":"89","author":"Chan","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2013.11.009_bib0090","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/RLU.0b013e3181e4dcbf","article-title":"Metabolic activity measured by F-18FDG PET in natural killer-cell lymphoma compared to aggressive B- and T-cell lymphomas","volume":"35","author":"Chan","year":"2010","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.canrad.2013.11.009_bib0095","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/CCO.0b013e3283556142","article-title":"Practical management of natural killer\/T-cell lymphoma","volume":"24","author":"Tse","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0100","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/jcp.2004.022608","article-title":"Diagnostic cues for natural killer cell lymphoma: primary nodal presentation and the role of in situ hybridisation for Epstein-Barr virus encoded early small RNA in detecting occult bone marrow involvement","volume":"58","author":"Chim","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0105","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1586\/era.10.130","article-title":"Risk stratification in extranodal natural killer\/T-cell lymphoma","volume":"10","author":"Kohrt","year":"2010","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.canrad.2013.11.009_bib0110","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2141.2011.08982.x","article-title":"Racial patterns of extranodal natural killer\/T-cell lymphoma, nasal type, in California: a population-based study","volume":"156","author":"Ai","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0115","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2214\/ajr.174.4.1741141","article-title":"Nasal T-cell\/natural killer cell lymphoma: CT and MR imaging features of a new clinicopathologic entity","volume":"174","author":"Ooi","year":"2000","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0120","series-title":"AJCC Cancer Staging Atlas","first-page":"91","article-title":"Nasal Cavity and Paranasal Sinuses","author":"Compton","year":"2012"},{"key":"10.1016\/j.canrad.2013.11.009_bib0125","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1182\/blood-2003-05-1401","article-title":"Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index","volume":"103","author":"Chim","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2013.11.009_bib0130","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood.V86.4.1460.bloodjournal8641460","article-title":"International Prognostic Index for aggressive non-Hodgkin's lymphoma is valid for all malignancy grades","volume":"86","author":"Hermans","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2013.11.009_bib0135","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/annonc\/mdp418","article-title":"Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type","volume":"21","author":"Suzuki","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0140","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1182\/blood-2011-05-354142","article-title":"Prospective measurement of Epstein-Barr virus DNA in plasma and peripheral blood mononuclear cells of extranodal NK\/T-cell lymphoma, nasal type","volume":"118","author":"Suzuki","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2013.11.009_bib0145","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1158\/1078-0432.CCR-12-1064","article-title":"Pre-treatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK\/T-cell lymphoma, nasal type","volume":"18","author":"Ito","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.canrad.2013.11.009_bib0150","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1470-2045(09)70265-7","article-title":"Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009","volume":"10","author":"Kwong","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0155","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1182\/blood-2013-01-453233","article-title":"How I treat NK\/T-cell lymphomas","volume":"121","author":"Tse","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2013.11.009_bib0160","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/annonc\/mdh143","article-title":"Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)\/T-cell lymphoma: a single institute survey in Taiwan","volume":"15","author":"You","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0165","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1080\/10428190600565651","article-title":"Treatment outcome of front-line systemic chemotherapy for localized extranodal NK\/T cell lymphoma in nasal and upper aerodigestive tract","volume":"47","author":"Kim","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.canrad.2013.11.009_bib0170","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1080\/10428190600562823","article-title":"First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy\u00b1radiotherapy is active in stage I\/II extranodal NK\/T-cell lymphoma","volume":"47","author":"Lee","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.canrad.2013.11.009_bib0175","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1023\/A:1011144911781","article-title":"CHOP followed by involved field radiation: is it optimal for localized nasal natural killer\/T-cell lymphoma?","volume":"12","author":"Kim","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0180","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1182\/blood.V93.2.599","article-title":"P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833","volume":"93","author":"Egashira","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2013.11.009_bib0185","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1002\/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1","article-title":"Frequent expression of P-glycoprotein\/MDR1\u00a0by nasal T-cell lymphoma cells","volume":"76","author":"Yamaguchi","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2013.11.009_bib0190","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00277-008-0669-3","article-title":"l-asparaginase in the treatment of refractory and relapsed extranodal NK\/T-cell lymphoma, nasal type","volume":"88","author":"Yong","year":"2009","journal-title":"Ann Hematol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0195","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1182\/blood-2010-09-307454","article-title":"Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK\/T-cell lymphoma, a phase 2\u00a0study","volume":"117","author":"Jaccard","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2013.11.009_bib0200","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1200\/JCO.2012.45.6541","article-title":"Concurrent chemoradiotherapy for localized nasal natural killer\/T-cell lymphoma: an updated analysis of the Japan Clinical Oncology Group Study JCOG0211","volume":"30","author":"Yamaguchi","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0205","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","article-title":"Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)\/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study","volume":"29","author":"Yamaguchi","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0210","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF02983387","article-title":"l-asparaginase-based regimen in the treatment of refractory midline nasal\/nasal-type T\/NK-cell lymphoma","volume":"78","author":"Yong","year":"2003","journal-title":"Int J Hematol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0215","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/cncr.21656","article-title":"Extranodal natural killer\/T-cell lymphoma, nasal type: the significance of radiotherapeutic parameters","volume":"106","author":"Isobe","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2013.11.009_bib0220","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1200\/JCO.2005.03.2573","article-title":"Radiotherapy as primary treatment for stage IE and IIE nasal natural killer\/T-cell lymphoma","volume":"24","author":"Li","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0225","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0360-3016(02)02916-4","article-title":"Early stage nasal NK\/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality","volume":"54","author":"Cheung","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.11.009_bib0230","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00277-012-1611-2","article-title":"Survival benefit with salvage radiotherapy for patients with locoregionally recurrent extranodal NK\/T cell lymphoma, nasal type","volume":"92","author":"Zhao","year":"2013","journal-title":"Ann Hematol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0235","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.canrad.2009.07.005","article-title":"Place de la radioth\u00e9rapie dans le traitement des lymphomes non hodgkiniens","volume":"13","author":"Quero","year":"2009","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2013.11.009_bib0240","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijrobp.2007.05.073","article-title":"Early or up-front radiotherapy improved survival of localized extranodal NK\/T-cell lymphoma, nasal-type in the upper aerodigestive tract","volume":"70","author":"Huang","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.11.009_bib0245","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1278-3218(00)00050-0","article-title":"Lymphomes primitifs nasosinusiens. \u00c0 propos de 25\u00a0cas","volume":"5","author":"Boussen","year":"2001","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2013.11.009_bib0250","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1200\/JCO.2009.23.8592","article-title":"Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK\/T-cell lymphoma: consortium for Improving Survival of Lymphoma Study","volume":"27","author":"Kim","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0255","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1200\/JCO.2009.23.8295","article-title":"Phase I\/II study of concurrent chemoradiotherapy for localized nasal natural killer\/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211","volume":"27","author":"Yamaguchi","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0260","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2012-05-431460","article-title":"SMILE for natural killer\/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group","volume":"120","author":"Kwong","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2013.11.009_bib0265","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/cncr.27752","article-title":"First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE\/IIE extranodal natural killer\/T-cell lymphoma","volume":"119","author":"Wang","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2013.11.009_bib0270","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/annonc\/mdh143","article-title":"Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)\/T-cell lymphoma: a single institute survey in Taiwan","volume":"15","author":"You","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0275","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1046\/j.1365-2257.2000.00307.x","article-title":"Angiocentric nasal T\/natural killer cell lymphoma: a single centre study of prognostic factors in 108\u00a0patients","volume":"22","author":"Avil\u00e9s","year":"2000","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0280","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ijrobp.2003.12.006","article-title":"Angiocentric T-cell and NK\/T-cell lymphomas: radiotherapeutic viewpoints","volume":"59","author":"Koom","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.11.009_bib0285","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0360-3016(02)02916-4","article-title":"Early stage nasal NK\/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality","volume":"54","author":"Cheung","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.11.009_bib0290","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.leu.2402148","article-title":"Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx","volume":"15","author":"Ribrag","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.canrad.2013.11.009_bib0295","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1002\/cncr.26167","article-title":"Failure patterns and clinical implications in early stage nasal natural killer\/T-cell lymphoma treated with primary radiotherapy","volume":"117","author":"Li","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2013.11.009_bib0300","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ijrobp.2011.02.039","article-title":"mild toxicity and favorable prognosis of high-dose and extended involved-field intensity-modulated radiotherapy for patients with early-stage nasal NK\/T-cell lymphoma","volume":"82","author":"Wang","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.11.009_bib0305","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1200\/JCO.2007.11.5501","article-title":"Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients","volume":"25","author":"Kam","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0310","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ijrobp.2006.06.013","article-title":"Xerostomia and quality of life after intensity-modulated radiotherapy vs conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial","volume":"66","author":"Pow","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.11.009_bib0315","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1259\/bjr\/83758373","article-title":"A comparison of radiation treatment plans using IMRT with helical tomotherapy and 3D conformal radiotherapy for nasal natural killer\/T-cell lymphoma","volume":"82","author":"Tomita","year":"2009","journal-title":"Br J Radiol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0320","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1182\/blood-2010-06-292268","article-title":"A novel latent membrane 2\u00a0transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy","volume":"116","author":"Fox","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2013.11.009_bib0325","first-page":"773","article-title":"[Clinical characteristics and treatment of midline nasal and nasal type NK\/T cell lymphoma]","volume":"81","author":"Yong","year":"2001","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.canrad.2013.11.009_bib0330","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/02841860310010682","article-title":"Therapeutic outcome of extranodal NK\/T-cell lymphoma initially treated with chemotherapy\u00a0\u2013\u00a0result of chemotherapy in NK\/T-cell lymphoma","volume":"42","author":"Kim","year":"2003","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2013.11.009_bib0335","first-page":"427","article-title":"The effect of pre-irradiation dose intense CHOP on anthracyline resistance in localized nasal NK\/T-cell lymphoma","volume":"91","author":"Lee","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.canrad.2013.11.009_bib0340","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1756-8722-6-44","article-title":"A prospective phase II study of l-asparaginase-CHOP plus radiation in newly diagnosed extranodal NK\/T-cell lymphoma, nasal type","volume":"6","author":"Lin","year":"2013","journal-title":"J Hematol Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321813004460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321813004460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:21:41Z","timestamp":1761135701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321813004460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1278321813004460"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2013.11.009","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radioth\u00e9rapie des lymphomes NK\/T localis\u00e9s aux fosses nasales","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2013.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}